Lingamneni Anila
- SEC CIK
- 0001808414
No open-market purchases or sales filed in the past year.
Current role at each company
- HAE Haemonetics CorpEVP, Chief Technology Officeras of Jul 15, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lingamneni Anila as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2024 (view filing) | Jul 11-12 | 4 days | Lingamneni AnilaEVP, Chief Technology Officer | SSale | −2.21K | $90.00 | −$199.3K | −9.4%21.3K after | 2 lots10b5-1 |
| May 8, 2024 (view filing) | May 6 | 2 days | Lingamneni AnilaEVP, Chief Technology Officer | SSale | −2.31K | $95.00 | −$219.0K | −15.8%12.3K after | 10b5-1 |
| Sep 13, 2023 (view filing) | Sep 11 | 2 days | Lingamneni AnilaEVP, Chief Technology Officer | SSale | −2.31K | $90.00 | −$207.4K | −13.7%14.5K after | 10b5-1 |
| Jun 1, 2023 (view filing) | May 30 | 2 days | Lingamneni AnilaEVP, Chief Technology Officer | SSale | −2.30K | $83.33 | −$192.0K | −12.1%16.8K after | |
| May 23, 2022 (view filing) | May 19 | 4 days | Lingamneni AnilaEVP, Chief Technology Officer | SSale | −1.38K | $59.10 | −$81.8K | −7.4%17.3K after | |
| Apr 19, 2022 (view filing) | Apr 18 | 1 day | Lingamneni AnilaEVP, Chief Technology Officer | SSale | −189 | $56.55 | −$10.7K | −1.3%14.0K after |